Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

29 June 2012

Association of transforming growth factor β1 (TGF- β1) with gingival hyperplasia in heart transplant patients undergoing cyclosporine-A treatment

Katarzyna PakoszABCDEFG, Michał ZakliczyńskiACEFG, Wojciech KrólADG, Łukasz PykaBEF, Helena ZakliczyńskaBC, Dominika TrybuniaEF, Rafał WienchB, Leszek IlewiczB, Bronisława Skrzep-PoloczekABG, Roman PrzybylskiABG, Marian ZembalaABG

DOI: 10.12659/AOT.883222

Ann Transplant 2012; 17(2): 45-52


Background: Gingival hyperplasia is a common complication of immunosuppressive therapy with cyclosporine A (CyA). However, the association of CyA with increased tissue concentrations of TGF- β1, a potential causative factor of hyperplasia, remains unknown. The aim of the study was to assess the impact of TGF- β1 and IL-2 on the development and maintenance of gingival hyperplasia in patients treated with CyA after orthotopic heart transplantation (OHT).
Material/Methods: Gingival hyperplasia was indexed in 60 patients, in accordance with McGraw and Potter scale. Patients were divided and comparisons were made among 3 groups: Group A (18 patients; 49.0±12.1 y/o) after OHT with gingival hyperplasia (score 1, 2, 3), Group B (12 patients; 40.0±15.1 y/o) after OHT without gingival hyperplasia (score 0), and Group C – the control group – (30 patients; 42.0±10.8 y/o) with clinically healthy paradentium. Cytokines (TGF- β1 and IL-2) were marked in gingival tissue homogenate. The concentration of CyA was marked in the patients’ blood (Groups A and B).
Results: The highest mean concentration of TGF- β1 was obtained in Group A and the lowest concentration was in the control group. A positive correlation was found between TGF- β1 in gingival tissue and CyA blood concentration in Groups A and B.
Conclusions: TGF- β1 is associated with gingival hyperplasia in patients treated with CyA after OHT procedure.

Keywords: Heart Transplantation, Cyclosporine-A, Gingival Hyperplasia, transforming growth factor beta 1, Interleukin-2


Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358